ZA201003573B - Pharmaceutical composition containing a zeoliter/algae or zeolite/emulsion combination for the treatment of aids - Google Patents

Pharmaceutical composition containing a zeoliter/algae or zeolite/emulsion combination for the treatment of aids

Info

Publication number
ZA201003573B
ZA201003573B ZA2010/03573A ZA201003573A ZA201003573B ZA 201003573 B ZA201003573 B ZA 201003573B ZA 2010/03573 A ZA2010/03573 A ZA 2010/03573A ZA 201003573 A ZA201003573 A ZA 201003573A ZA 201003573 B ZA201003573 B ZA 201003573B
Authority
ZA
South Africa
Prior art keywords
zeoliter
algae
zeolite
aids
treatment
Prior art date
Application number
ZA2010/03573A
Other languages
English (en)
Inventor
Axel Siegner
Original Assignee
Neopharmacie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neopharmacie Gmbh filed Critical Neopharmacie Gmbh
Publication of ZA201003573B publication Critical patent/ZA201003573B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
ZA2010/03573A 2007-11-23 2010-05-20 Pharmaceutical composition containing a zeoliter/algae or zeolite/emulsion combination for the treatment of aids ZA201003573B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007056424A DE102007056424A1 (de) 2007-11-23 2007-11-23 Pharmazeutische Zusammensetzung, enthaltend eine Öl/Wasser-Emulsion
PCT/EP2008/066033 WO2009065947A2 (de) 2007-11-23 2008-11-21 Pharmazeutische zusammensetzung, enthaltend eine zeolith/algen- oder zeolith/emulsions-kombination zur behandlung von aids

Publications (1)

Publication Number Publication Date
ZA201003573B true ZA201003573B (en) 2011-04-28

Family

ID=40457343

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA2010/03574A ZA201003574B (en) 2007-11-23 2010-05-20 Pharmaceutical kit consisting of an oil-water emulsion and a solid composition
ZA2010/03573A ZA201003573B (en) 2007-11-23 2010-05-20 Pharmaceutical composition containing a zeoliter/algae or zeolite/emulsion combination for the treatment of aids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ZA2010/03574A ZA201003574B (en) 2007-11-23 2010-05-20 Pharmaceutical kit consisting of an oil-water emulsion and a solid composition

Country Status (6)

Country Link
EP (1) EP2259789A2 (de)
AP (2) AP2010005274A0 (de)
DE (1) DE102007056424A1 (de)
RU (2) RU2010125505A (de)
WO (2) WO2009065946A2 (de)
ZA (2) ZA201003574B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2545788A1 (de) * 2011-07-13 2013-01-16 Martin Hulliger Diätisches Mehrkomponentensystem
RU2708161C1 (ru) * 2019-04-16 2019-12-05 Иван Павлович Уваров Кормовая комплексная биологически активная добавка для животных и птиц

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
CN1292699A (zh) * 1998-03-16 2001-04-25 宝洁公司 皮肤刺激的处理方法
DE19940011B4 (de) * 1999-08-24 2009-04-02 Schütte/Reichel GbR (vertretungsberechtigte Gesellschafter: Irene Schütte Alginataufbereitung und deren Verwendung
US20060122082A1 (en) * 2000-02-17 2006-06-08 Leonard Paul Foam/spray producing compositions and dispensing system therefor
US20030216364A1 (en) * 2001-08-13 2003-11-20 Johnson Keith Arthur Dermatological Formulation
US20050058672A1 (en) * 2003-09-14 2005-03-17 Bioderm Research Baby Care Skin Protectant Compositions for Diaper Rash
RU2350333C3 (ru) * 2003-04-24 2018-08-24 Галдерма С.А. Применение ивермектина для лечения дерматологических расстройств
US20040253323A1 (en) * 2003-06-11 2004-12-16 Giles Brian C. Ionic cancer therapy and methods for using same in the treatment of tumors and metastasis
US7485451B2 (en) * 2004-11-18 2009-02-03 Regents Of The University Of California Storage stable compositions of biological materials
DE102005009515A1 (de) * 2005-02-25 2006-09-07 Exner, Heinrich, Dr. Verfahren zur Herstellung einer Zubereitung einer DMSO-haltigen festen Silikonölemulsion zur Bindung von reaktiven Sauerstoffverbindungen im Körper von Menschen und Tieren
US20070031512A1 (en) * 2005-08-03 2007-02-08 Amcol International Corporation Virus-interacting layered phyllosilicates and methods of inactivating viruses
WO2007032727A1 (en) * 2005-09-16 2007-03-22 Dsm Ip Assets B.V. Particulate lipid pharmaceutical composition
EP1956920A1 (de) * 2005-11-22 2008-08-20 Nestec S.A. Leicht dispergierbare lipidphase
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
GB0602528D0 (en) * 2006-02-08 2006-03-22 Ici Plc Emulsification systems, emulsions and wet wipes containing such emulsions
EP1988918A4 (de) * 2006-02-22 2010-04-28 Novavax Inc Adjuvanz- und impfstoffzusammensetzungen
CA2645080A1 (en) * 2006-03-07 2007-09-13 Novavax,Inc. Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same

Also Published As

Publication number Publication date
AP2010005275A0 (en) 2010-06-30
ZA201003574B (en) 2011-02-23
WO2009065946A3 (de) 2009-07-16
DE102007056424A1 (de) 2009-05-28
EP2259789A2 (de) 2010-12-15
WO2009065947A3 (de) 2009-11-19
WO2009065946A2 (de) 2009-05-28
AP2010005274A0 (en) 2010-06-30
RU2010125505A (ru) 2011-12-27
RU2496506C2 (ru) 2013-10-27
WO2009065947A2 (de) 2009-05-28
RU2010125503A (ru) 2011-12-27

Similar Documents

Publication Publication Date Title
IL195571A0 (en) Compounds for the treatment of periodontal disease
HK1131141A1 (en) Imidazolothiazole compounds for the treatment of disease
EP2040721A4 (de) Honig enthaltende medizinische zusammensetzungen
ME01944B (me) Farmaceutske kompozicije koje sadrže rozuvastatin kalcijum
EP2124878A4 (de) Erhöhte effektivität von allylamin-heilmittelverbindungen
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
EP1976377A4 (de) Verbindungen zur behandlung von stoffwechselstörungen
PL1975226T3 (pl) Płynna kompozycja do obróbki
EP1983972A4 (de) Verbindungen zur behandlung von stoffwechselstörungen
ZA200805716B (en) Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
IL195203A0 (en) Compounds for the treatment of metabolic disorders
HK1132458A1 (en) Ophthalmic composition containing alginic acid or salt thereof
IL192852A0 (en) Compounds for the treatment of metabolic disorders
IL209360A (en) Medications containing pm00104 for the treatment of multiple myeloma
EP2213303A4 (de) Pharmazeutische zusammensetzung zur behandlung von katarakt
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
EP2170049A4 (de) Verbindungen und zusammensetzungen zur schädlingsbekämpfung
IL192851A0 (en) Compounds for the treatment of metabolic disorders
ZA201003573B (en) Pharmaceutical composition containing a zeoliter/algae or zeolite/emulsion combination for the treatment of aids
IL195392A0 (en) Compounds for the treatment of metabolic disorders
HUP0500685A2 (en) Pharmaceutical composition for the treatment of psychosis
GB0604782D0 (en) Use of substituted pyrimidinyl-2-piperazine compounds for the treatment of food related disorders
HK1120034A1 (en) Pharmaceuticals for treating or preventing oral diseases
IL192982A0 (en) Compounds for the treatment of metabolic disorders
EP2149549A4 (de) Pharmazeutische zusammensetzung zur prävention oder behandlung von häpatitis